Patent application number | Description | Published |
20100267621 | Antimicrobial Compounds and Formulations - The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilising microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics. | 10-21-2010 |
20110143384 | METHODS OF PEPTIDE MODIFICATION - The present invention relates to a method of improving the resistance of a peptide or peptidomimetic to degradation by trypsin which comprises incorporating into said peptide or peptidomimetic a C-terminal capping group of formula (I): X—Y—Z (I) wherein X is a N atom, which may be substituted by a branched or unbranched C | 06-16-2011 |
20110236453 | TREATMENT OF BIOFILMS - The present invention relates to a peptide or peptidomimetic for use in the treatment of a biofilm-associated infection in a subject, wherein said peptide or peptidomimetic a) carries a net positive charge, b) is 1 to 6 amino acids in length or is an equivalently sized peptidomimetic; and c) is amphipathic in nature, having one or more lipophilic groups, one of said lipophilic groups comprising at least 7 non-hydrogen atoms. | 09-29-2011 |
20110318364 | NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY - The present invention relates to peptides or peptide like molecules and their uses in therapy, in particular as anti-tumour agents. | 12-29-2011 |
20120108520 | Antimicrobial Compounds and Formulations - The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilising microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics. | 05-03-2012 |
20140037657 | INHIBITION OF TUMOR GROWTH - The present invention provides a cytotoxic 7 to 25 mer peptide with three or more cationic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them and their use as medicaments, particularly as antibacterions or antitumoral agents. In a preferred aspect, the invention provides the use of said peptides in a method of inducing adaptive immunity against tumor growth or establishment in a subject, as well as the use of other lytic agents in a method of inducing adaptive immunity in a subject. | 02-06-2014 |
Patent application number | Description | Published |
20090296520 | ACQUIRING NEAR ZERO OFFSET SURVEY DATA - To acquire near-zero offset survey data, a survey source and a first streamer attached to the survey source are provided, where the first streamer has at least one survey receiver. A second streamer separate from the survey source and the first streamer includes survey receivers. Near-zero offset data is measured using the at least one survey receiver of the first streamer. | 12-03-2009 |
20100302901 | SYSTEM AND METHOD OF USING AUTONOMOUS UNDERWATER VEHICLE TO FACILITATE SEISMIC DATA ACQUISITION - A technique facilitates the use of seismic data. The technique utilizes an autonomous underwater vehicle to obtain data on water column characteristics in a seismic survey area. The data can be used to adjust aspects of the seismic survey data and/or the seismic survey technique. | 12-02-2010 |
20120020185 | Collision Avoidance for Instrumented Probes Deployed From a Seismic Vessel - One embodiment of the invention concerns a probe that couples to a seismic vessel via a tow cable. When deploying probes from a seismic vessel that is towing source arrays and streamers, the probe and its tow cable can tangle with elements of the towed seismic spread. However, a cable guide may be used to lessen the risk for such entanglement by guiding the tow cable into the water at a distance removed from the seismic spread. Also, the probe may be steerable to steer the probe and tow cable away from the seismic spread. Other embodiments are described herein. | 01-26-2012 |
20130279291 | ACQUIRING NEAR-ZERO OFFSET SURVEY DATA - To acquire near-zero offset survey data, a survey source and a first streamer attached to the survey source are provided, where the first streamer has at least one survey receiver. A second streamer separate from the survey source and the first streamer includes survey receivers. Near-zero offset data is measured using the at least one survey receiver of the first streamer. | 10-24-2013 |
Patent application number | Description | Published |
20090295126 | SPRING CARTRIDGE FOR SKI BINDING - The present invention relates to a spring cartridge for a ski binding, wherein the ski binding has a rotatable front binding part for attachment of a ski boot, and is in particular a telemark ski binding. In the binding the spring cartridge provides tension to a biasing cable which biases the rotatable front binding part, so as to rotate the front binding part so that an attached ski boot would be brought into contact with the ski to which the ski binding is attached. | 12-03-2009 |
20120175860 | FLEXOR WITH FASTENING CLIP - The present invention relates to a multi-element flexor unit ( | 07-12-2012 |
20120187643 | FLEXOR WITH EXTENDING FLEXOR ARM | 07-26-2012 |
20120205896 | LOCKING MECHANISM FOR SKI BINDING - The present disclosure relates to a single piece base portion ( | 08-16-2012 |
20140319803 | FLEXOR WITH FASTENING CLIP - A flexor unit for a ski binding, in particular a cross country or touring ski binding, including a flexor element which is attached, attachable or integrally formed with a base element for interaction and attachment with the ski binding in a removable manner, the flexor element comprising a single piece double section element with a front flexor portion and a rear flexor portion, the flexor element further including a pin receiving slot between the front and rear flexor portions, the pin receiving slot being sized and shaped to receive a rotation pin of a ski boot. | 10-30-2014 |
20140327230 | LOCKING MECHANISM FOR SKI BINDIN - The present disclosure relates to a single piece base portion ( | 11-06-2014 |
20140333047 | LOCKING MECHANISM FOR SKI BINDIN - The present disclosure relates to a single piece base portion ( | 11-13-2014 |
20140333048 | LOCKING MECHANISM FOR SKI BINDIN - The present disclosure relates to a single piece base portion ( | 11-13-2014 |
Patent application number | Description | Published |
20100303914 | Self-Gelling Alginate Systems and Uses Thereof - Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed. | 12-02-2010 |
20110021832 | SYNTHESIS OF IODIXANOL IN WATER - This invention relates to the synthesis of iodixanol (1,3-bis(acetamido)-N,N′-bis[3,5-bis(2,3-dihydroxypropylaminocarbonyl)-2,4,6-triiodophenyl]-2-hydroxypropane), more specifically to the dimerisation of 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-isophthalamide with water as solvent. | 01-27-2011 |
20110053886 | Delayed Self-Gelling Alginate Systems and Uses Thereof - Dispersions that comprise insoluble alginate/gelling ion particles in an alginate solution, wherein the dispersion exhibits less than 10% of final gel storage modulus after one minute in the absence of addition of non-gelling cations are disclosed. Kits and compositions for making such dispersions are disclosed and methods for making and using the dispersions, and the components used in the dispersions are also disclosed. | 03-03-2011 |
20130288998 | Self-Gelling Alginate Systems and Uses Thereof - Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed. | 10-31-2013 |
20140271576 | Self-Gelling Alginate Systems and Uses Thereof - Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed. | 09-18-2014 |